Investors

Date	Name	Title	Type	Shares Traded	Price Range
Dec 18, 2012	terifay robert j	Officer	Option Execute	5,952	16.80
Jul 27, 2012	terifay robert j	Officer	Option Execute	50,875	16.80 - 21.92
May 7, 2013	terifay robert j	Officer	Option Execute	16,923	16.80
May 6, 2013	van plew daniel p	Officer	Option Execute	32,950	16.80
Dec 20, 2012	van plew daniel p	Officer	Option Execute	2,050	16.80
Dec 16, 2008	yancopoulos george	Officer	Automatic Sell	74,859	16.40 - 16.42
Jul 1, 2011	brown michael s	Director	Option Execute	25,000	15.80 - 28.81
Mar 1, 2012	brown michael s	Director	Option Execute	20,000	15.80 - 19.69
Aug 7, 2012	gilman alfred g	Director	Option Execute	15,000	15.80
Feb 10, 2011	goldstein joseph l	Director	Option Execute	5,000	15.80
Jan 26, 2011	goldstein joseph l	Director	Option Execute	10,000	15.80
Jan 21, 2010	shooter eric m	Director	Option Execute	15,000	15.80
Aug 1, 2012	powchik peter	Officer	Option Execute	14,990	15.64 - 21.92
Feb 21, 2012	powchik peter	Officer	Option Execute	109,866	15.64 - 21.92
Aug 1, 2011	powchik peter	Officer	Option Execute	15,144	15.64
Jul 25, 2011	powchik peter	Officer	Option Execute	25,000	15.64
Sep 5, 2012	baker charles a	Director	Option Execute	1,286	15.01
Sep 6, 2012	baker charles a	Director	Option Execute	13,714	15.01
Jan 18, 2011	brown michael s	Director	Option Execute	10,000	15.01 - 18.80
Mar 9, 2011	brown michael s	Director	Option Execute	5,000	15.01
Showing 421-440 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.